Search

Your search keyword '"Francesca Girolami"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Francesca Girolami" Remove constraint Author: "Francesca Girolami" Topic cardiology and cardiovascular medicine Remove constraint Topic: cardiology and cardiovascular medicine
50 results on '"Francesca Girolami"'

Search Results

1. Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM

2. Natural History of MYH7-Related Dilated Cardiomyopathy

Catalog

Books, media, physical & digital resources

3. Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia

4. 263 GENETIC CAUSES OF CARDIOMYOPATHIES IN CHILDREN

5. Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry

6. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy

7. Phospholamban Cardiomyopathy: Unveiling a Distinct Phenotype Through Heart Failure Stages Progression

8. Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome

9. Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing

10. 749 Clinical profile and outcome of patients with Anderson–Fabry disease followed at a multidisciplinary cardiomyopathy centre

11. The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy

12. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy

13. Hidden familial cardiomyopathies in children: Role of genetic testing

14. Prevalence of adverse cardiovascular events in pediatric cardiomyopathies: an analysis of 110 patients followed at a long-standing tertiary care paediatric centre

15. The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases

16. Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?

17. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

18. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy

19. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

20. 1177Insights on mitochondrial energetics in obstructive hypertrophic cardiomyopathy

21. Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy

22. P3167Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy

23. 145Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy

24. P2594Prevalence of cardiac amyloidosis by age-class in patients presenting with hypertrophic cardiomyopathy

25. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy Results From the International Sarcomeric Human Cardiomyopathy Registry

26. Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications

27. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

28. Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy

29. An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy

30. Genetic advances in sarcomeric cardiomyopathies: state of the art

31. 124Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy

32. P4506Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome

33. P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes

34. Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation

35. Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations

36. Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy

37. Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations

38. Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events

39. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression

40. Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

41. Looking for Hypertrophic Cardiomyopathy in the Community: Why Is It Important?

42. Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

43. A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy

44. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study

45. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy

46. The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice

47. 1032-119 Prevalence of mutations in the cardiac myosin-binding protein C gene among tuscan patients with hypertrophic cardiomyopathy

48. Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany

49. A novel desmoplakin dominant mutation responsible for Carvajal/Naxos syndrome identified by exome sequencing

50. Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy